NCCN 2010: Dr. Mark Kris, Memorial Sloan-Kettering Cancer Center
NCCN 2010: Dr. Len Saltz, Memorial Sloan-Kettering Cancer Center
NCCN 15th Annual Conference Overview, Resources, and Upcoming Meetings
During the the National Comprehensive Cancer Network 15th Annual Conference, updates were presented for various NCCN Clinical Practice Guidelines.
Treatment-Related Infections, Thromboses, and Neuropathy in Cancer
Many cancers increase the risk of other serious events and many treatments have their own risks and adverse effects that must be managed.
NCCN Guidelines Are Being Adopted Internationally
NCCN is increasingly collaborating with other nations to develop foreign editions of its guidelines.
Survival for Youths with Cancers Remains Stagnant
When adolescents and young adults develop cancer, clinicians contend with an entirely different set of considerations in treatment and follow-up.
NCCN 2010: Dr. David Pfister, Memorial Sloan-Kettering Cancer Center
NCCN 2010: Dr. Lee Krug, Memorial Sloan-Kettering Cancer Center
Neuroendocrine Tumors: Sometimes You Need to 'Sit Tight'
New treatments are desperately needed for neuroendocrine tumors, said Leonard Saltz, MD, Memorial Sloan-Kettering Cancer Center.
NCCN Multiple Myeloma Guidelines Updates
George Somlo, MD, City of Hope Comprehensive Cancer Center, presented the updates to the NCCN Multiple Myeloma Guidelines.
New NCCN Guidelines for Malignant Pleural Mesothelioma
These new guidelines were presented by Lee M. Krug, MD, Memorial Sloan-Kettering Cancer Center.
Impact of Evidence-Based Guidelines on Cancer Care and Cost
The escalating costs of cancer care combined with variations in concordance with evidence-based practice guidelines is could collapse the US Healthcare System.
Taking Steps to Identify Carcinoma of Unknown Primary
At NCCN, Richard Klausner, MD, gave a spirited presentation on "New Advances in Molecular Diagnostics and Cancer."
NCCN Gastrointestinal Stromal Tumor Updates
This year's updates parse sarcomas, emphasize the importance of accurate pathology evaluations, and examine the value of molecular testing.
Reviewing Initial Therapy and Maintenance in NSCLC
NCCN included a dinner symposium on Maintenance Therapy for Non-Small Cell Lung Cancer.
Overview of NCCN Colon and Rectal Guideline Updates
Paul F. Engstrom, MD, reviewed the recent changes to the National Comprehensive Cancer Network guidelines for colon and rectal cancer.
NCCN Acute Myeloid Leukemia Updates
At NCCN, B. Douglas Smith, MD, presented updates to the NCCN Acute Myeloid Leukemia Guidelines.
NCCN Occult Primary Guidelines Update
At NCCN, David Ettinger, MD, presented updates to the NCCN Occult Primary Guidelines.
NCCN Breast Cancer Updates
An NCCN panel reviewed changes to the NCCN Breast Cancer Guidelines for invasive breast cancer.
NCCN Developing Guidelines for Specialty Pharmacy in Oncology
Specialty pharmacies are meant to address gaps in care provided by community pharmacy practices.
HPV Oncogenic in Head and Neck and Anal Cancer
For some time, medical science has recognized that the human papilloma virus (HPV) causes nearly all cases of cervical cancer.
NCCN Prostate Cancer Guidelines Update: To Screen and Treat or Not?
Updates to the NCCN Prostate Cancer Guidelines were presented by James L. Mohler, MD.
